Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin Transdermal and Gel Heat/Occlusion Study
NCT03205605Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of oxybutynin in overactive bladder (OAB), sponsored by University of Maryland, Baltimore. Started Jan 2018; status: completed.
02
Drugs
oxybutynin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03205605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205605.